greeksoup/ stock research

Johnson & Johnson (JNJ) FY2023 results: revenue $85.2 billion, up 6.5% on the year

Johnson & Johnson (JNJ) reported revenue of $85.2 billion for fiscal 2023, the year ended 31 December 2023, up 6.5% on the year before. Net income was $35.2 billion, up 95.9%, and diluted earnings per share $13.72. The figures are the company's own, from the 10-K it filed with the SEC on 16 February 2024.

Revenue
$85.2 billion
+6.5% on the year
FY2016FY2023
Operating margin
n/a
FY2016FY2023
Net income
$35.2 billion
+95.9% on the year
FY2016FY2023
Diluted EPS
$13.72
+103.9% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue85,15979,99078,740+6.5%
Cost of revenue26,55324,59623,402+8.0%
Gross profit58,60655,39455,338+5.8%
Gross margin68.8%69.3%70.3%
Research and development4830.00.0
Selling, general and administrative21,51220,24620,118+6.3%
Interest expense772276183+179.7%
Pre-tax income15,06219,35919,178-22.2%
Income tax1,7362,9891,377-41.9%
Effective tax rate11.5%15.4%7.2%
Net income35,15317,94120,878+95.9%
Net margin41.3%22.4%26.5%
Diluted EPS$13.72$6.73$7.81+103.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow22,79121,19423,410+7.5%
Capital expenditure4,5434,0093,652+13.3%
Free cash flow18,24817,18519,758+6.2%
Free cash flow margin21.4%21.5%25.1%
Cash from investing878-12,371-8,683
Cash from financing-15,825-8,871-14,047
Depreciation and amortisation7,4866,9707,390+7.4%
Share-based compensation1,1621,1381,135+2.1%
Buybacks5,0546,0353,456-16.3%
Dividends paid11,77011,68211,032+0.8%
Dividend per share$4.70$4.45$4.19+5.6%
Diluted shares, weighted2,560m2,664m2,674m-3.9%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity68,77476,80474,023-10.5%
Non-controlling interestn/a0.0n/a
Debt29,33239,64233,751-26.0%
Other liabilities69,45270,93274,244-2.1%
Total liabilities and equity167,558187,378182,018-10.6%
Fixed assets19,89817,98218,962+10.7%
Goodwill36,55836,04725,436+1.4%
Intangible assets34,17538,48946,392-11.2%
Investments1,0689,39217,121-88.6%
Cash and equivalents21,85912,88914,487+69.6%
Receivables14,87314,03915,283+5.9%
Inventory11,18110,26810,387+8.9%
Other assets27,94648,27233,950-42.1%
Total assets167,558187,378182,018-10.6%

10-K for the year ended 31 December 2023, filed 16 February 2024: the filing.